Skip to search formSkip to main contentSkip to account menu

The Overactive Bladder Questionnaire

Known as: OAB-q, OABQ01 
A standardized survey developed and published by K. Coyne and colleagues in 2002 in the journal Quality of Life Research which is used to evaluate… 
National Institutes of Health

Related topics

Related topics

2 relations
CDISC Questionnaire Category TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Responder and health‐related quality of life analyses in men with lower urinary tract symptoms treated with a fixed‐dose combination of solifenacin and tamsulosin oral‐controlled absorption system…
To evaluate the effect of a fixed‐dose combination (FDC) of solifenacin and an oral‐controlled absorption system (OCAS… 
2015
2015
Patients With Prostatic Inflammation Undergoing Transurethral Prostatic Resection Have a Larger Early Improvement of Storage Symptoms.
2013
2013
Success rates, quality of life, and feasibility of sacral nerve stimulation in elderly patients: 1-year follow-up
Introduction and hypothesisUrgency urinary incontinence (UUI) frequently occurs in elderly. International guidelines recommend… 
2013
2013
Post hoc responder analyses of subjective and objective outcomes using pooled data from 3 randomised Phase III trials of mirabegron in patients with overactive bladder
Hypothesis / aims of study In a pre-defined, pooled analysis of three large, randomised, double-blind, placebo-controlled, 12… 
2012
2012
Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: A post hoc, pooled analysis from two placebo‐controlled trials
To assess the efficacy and tolerability of fesoterodine 8 mg versus tolterodine extended release (ER) 4 mg in subjects with… 
2011
2011
Patient‐optimized doses of fesoterodine improve bladder symptoms in an open‐label, flexible‐dose study
Study Type – Therapy (cohort) 
2010
2010
Efficacy of Solifenacin on Symptom Bother and Health-Related Quality of Life in Patients With Acute, Early Chronic, and Late Chronic Overactive Bladder: Secondary Analysis of Data From the VOLT Study
Objectives: In many clinical trials of pharmacotherapy for overactive bladder (OAB), the duration of symptoms is reported as a… 
2009
2009
Patient-reported most bothersome symptoms in OAB: post hoc analysis of data from a large, open-label trial of solifenacin
Introduction and hypothesisIn overactive bladder (OAB), subjects' most bothersome symptom (MBS) may influence treatment-related… 
2008
2008
Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms*
ABSTRACT Objective: To evaluate the efficacy of tolterodine extended release (ER) versus placebo at 1 and 12 weeks using… 
Highly Cited
2006
Highly Cited
2006
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)